Sovaldi and Harvoni to pay attention to getting health insurance benefit

The industry has paid attention if the expensive hepatitis C drugs, ‘Sovaldi’ and ‘Harvoni’ will receive the health insurance benefit this year.

According to the industry concerned on the 5^th, the Health Insurance Benefit Deliberation Committee, an affiliated organization of the Health Insurance Review & Assessment Service, is working on deliberating propriety of Harvoni(sofosbuvir+ledipasvir)...